Table: Kobayashi Pharmaceutical - 9-MTH group results
Oct 28 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2021 Sep 30, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 107.66 105.05 156.00
(+2.5 pct) (-5.5 pct) (+3.6 pct)
Operating 19.43 19.52 26.00
(-0.5 pct) (-1.6 pct) (+0.2 pct)
Recurring 21.02 21.04 27.80
(-0.1 pct) (-1.9 pct) (+0.3 pct)
Net 14.88 15.26 19.50
(-2.5 pct) (+0.1 pct) (+1.5 pct)
EPS 190.42 yen 195.21 yen 249.48 yen
Ann Div 77.00 yen 81.00 yen
-Q2 div 37.00 yen 34.00 yen
-Q4 div 43.00 yen 44.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows